company CING - SteadyBase

steadybase-$ company CING

account_id none on file

legal_name Cingulate Inc.

ticker CING

cik 1862150

domain cingulate.com

linkedin_company_url https://www.linkedin.com/company/cingulatetherapeutics/?viewAsMember=true

entry_point_account_id none on file

exchange Nasdaq

sector Health Care

irhttps://www.cingulate.com/investors

sector index/company/sector/health-care/

calls 0 filings 14 executives 3 family 0

why_nownone on file

callsnone on file

filings

SG&A expenses also include insurance, office, and travel expenses. We expect that our SG&A expenses will increase in the future as we increase our SG&A headcount to support our growing operations, including the potential commercialization of CTx-1301, and incur costs related to pre-commercialization activities.

filing / Aug 13, 2026 / receipt

of the year, including headcount additions and expanded market access, pricing, reimbursement, and medical affairs activity through Indegene,

filing / Aug 13, 2026 / receipt

May 2025, the Company executed a lease to renew the office space for its headquarters in Kansas City, Kansas. The lease has a five-year

filing / Aug 13, 2026 / receipt

SG&A expenses also include insurance, office, and travel expenses. We expect that our SG&A expenses will increase in the future as we increase our SG&A headcount to support our growing operations, including the potential commercialization of CTx-1301, and incur costs related to pre-commercialization activities.

filing / Aug 13, 2026 / receipt

of the year, including headcount additions and expanded market access, pricing, reimbursement, and medical affairs activity through Indegene,

filing / Aug 13, 2026 / receipt

May 2025, the Company executed a lease to renew the office space for its headquarters in Kansas City, Kansas. The lease has a five-year

filing / Aug 13, 2026 / receipt

Callahan’s base salary as Chief Financial Officer was reduced to $210,000, effective December 16, 2023. In September 2024, Ms.